PRGO - Perrigo Co PLC Stock Price, Fair Value and News

33.07USD+0.17 (+0.52%)Market Closed

Market Summary

USD33.07+0.17

Market Closed

0.52%

PRGO Stock Price

View Fullscreen

PRGO RSI Chart

PRGO Valuation

Market Cap

4.5B

Price/Earnings (Trailing)

-352.87

Price/Sales (Trailing)

0.96

EV/EBITDA

41.52

Price/Free Cashflow

14.75

PRGO Price/Sales (Trailing)

PRGO Profitability

EBT Margin

-0.18%

Return on Equity

-0.27%

Return on Assets

-0.12%

Free Cashflow Yield

6.78%

PRGO Fundamentals

PRGO Revenue

Revenue (TTM)

4.7B

Rev. Growth (Yr)

0.15%

Rev. Growth (Qtr)

2.95%

PRGO Earnings

Earnings (TTM)

-12.7M

Earnings Growth (Yr)

-36.29%

Earnings Growth (Qtr)

-327.46%

Breaking Down PRGO Revenue

Last 7 days

5.8%

Last 30 days

5.6%

Last 90 days

2.5%

Trailing 12 Months

-11.8%

How does PRGO drawdown profile look like?

PRGO Financial Health

Current Ratio

1.79

Debt/Equity

0.76

Debt/Cashflow

0.11

PRGO Investor Care

Dividend Yield

3.3%

Dividend/Share (TTM)

1.09

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-0.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.6B	4.6B	4.7B	4.7B
2022	4.2B	4.3B	4.4B	4.5B
2021	4.3B	4.3B	4.3B	4.1B
2020	4.7B	4.5B	4.4B	4.3B
2019	4.7B	4.7B	4.7B	4.8B
2018	5.0B	4.9B	4.8B	4.7B
2017	5.1B	5.0B	5.0B	4.9B
2016	5.4B	5.3B	5.3B	5.3B
2015	4.0B	4.2B	4.6B	5.0B
2014	3.9B	4.1B	4.0B	4.0B
2013	3.4B	3.5B	3.7B	3.8B
2012	0	3.2B	3.3B	3.4B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Perrigo Co PLC

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 07, 2024	janish ronald craig	acquired	87,348	29.69	2,942	evp, gbl ops & sc & cto
Mar 07, 2024	willis robert	sold (taxes)	-33,401	29.69	-1,125	evp & chro
Mar 07, 2024	ives alison	sold (taxes)	-15,616	29.69	-526	evp & chief scientific officer
Mar 07, 2024	janish ronald craig	sold (taxes)	-26,305	29.69	-886	evp, gbl ops & sc & cto
Mar 07, 2024	ives alison	acquired	51,838	29.69	1,746	evp & chief scientific officer
Mar 07, 2024	quinn grainne	sold (taxes)	-34,737	29.69	-1,170	evp, chief medical officer
Mar 07, 2024	quinn grainne	acquired	66,772	29.69	2,249	evp, chief medical officer
Mar 07, 2024	andersen svend	acquired	162,345	29.69	5,468	evp & president chci
Mar 07, 2024	willis robert	acquired	64,219	29.69	2,163	evp & chro
Mar 06, 2024	janish ronald craig	sold (taxes)	-19,466	28.09	-693	evp, gbl ops & sc & cto

Which funds bought or sold PRGO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 01, 2024	BNP PARIBAS FINANCIAL MARKETS	added	230	4,952,420	7,101,530	0.01%
May 01, 2024	Sachetta, LLC	unchanged	-	-	548	-%
May 01, 2024	BOK Financial Private Wealth, Inc.	sold off	-100	-2,060	-	-%
May 01, 2024	Janney Montgomery Scott LLC	added	31.77	424,000	1,759,000	-%
May 01, 2024	MEITAV INVESTMENT HOUSE LTD	unchanged	-	207	667,395	0.01%
May 01, 2024	Parkside Financial Bank & Trust	added	24.4	8,187	41,687	0.01%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	added	0.94	332	34,507	-%
May 01, 2024	Mirae Asset Global Investments Co., Ltd.	sold off	-100	-927,202	-	-%
May 01, 2024	Blue Trust, Inc.	reduced	-18.57	-9,215	40,785	-%
Apr 30, 2024	Private Advisor Group, LLC	reduced	-11.11	-33,245	266,427	-%

Are Funds Buying or Selling PRGO?

Are funds buying PRGO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PRGO

No. of Funds

Unveiling Perrigo Co PLC's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	barrow hanley mewhinney & strauss llc	12.%	10	SC 13G
Feb 13, 2024	vanguard group inc	11.07%	14,994,309	SC 13G/A
Jan 24, 2024	blackrock inc.	9.8%	13,342,622	SC 13G/A
Feb 15, 2023	barrow hanley mewhinney & strauss llc	7.30%	9,825,539	SC 13G
Feb 14, 2023	price t rowe associates inc /md/	0.1%	78,305	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	0.1%	78,305	SC 13G/A
Feb 09, 2023	vanguard group inc	10.84%	14,590,276	SC 13G/A
Jan 24, 2023	blackrock inc.	9.8%	13,221,594	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	8.0%	10,721,574	SC 13G/A
Feb 03, 2022	blackrock inc.	8.6%	11,557,239	SC 13G/A

Recent SEC filings of Perrigo Co PLC

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	8-K	Current Report
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading

Peers (Alternatives to Perrigo Co PLC)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	360.8B	85.6B	-4.95%	-7.94%	9.38	4.21	5.68%	202.39%
MRK	324.7B	60.1B	-1.63%	8.46%	889.69	5.4	1.40%	-97.49%
PFE	156.4B	46.5B	0.51%	-27.98%	-112.61	3.36	42.59%	-114.62%
AMGN	149.2B	28.2B	0.79%	21.40%	22.21	5.29	7.09%	2.52%
GILD	81.4B	27.1B	-9.38%	-17.77%	14.37	3	-0.60%	23.36%
TEVA	15.7B	15.8B	1.44%	59.77%	-27.34	0.99	6.17%	76.47%
MID-CAP
PRGO	4.5B	4.7B	5.59%	-11.79%	-352.87	0.96	4.58%	90.97%
ALKS	4.0B	1.7B	-10.87%	-16.72%	9.29	2.34	54.01%	364.56%
BHC	3.0B	9.0B	-20.59%	9.46%	-6.53	0.33	10.01%	-27.45%
AMPH	2.1B	644.4M	0.80%	17.68%	14.92	3.18	29.14%	50.51%
SMALL-CAP
TLRY	1.6B	743.2M	-16.18%	-15.48%	-4.44	2.1	24.65%	80.36%
TXMD	21.8M	1.3M	-16.00%	-50.65%	-2.12	16.74	-98.14%	-109.18%
ACRX	17.1M	-	2.02%	57.81%	-0.93	0.22	2882.68%	-138.52%
AGRX	2.6M	19.6M	48.15%	-93.36%	-0.18	0.13	80.00%	43.08%
ACOR	1.1M	117.6M	-94.70%	-92.62%	0	0.01	-0.79%	-283.60%

Perrigo Co PLC News

Latest updates

Perrigo Co PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	2.9%	1,157	1,124	1,193	1,182	1,155	1,100	1,122	1,075	1,105	1,043	981	1,010	1,290	1,003	949	1,083	1,323	1,191	1,149	1,175	1,195
Gross Profit	3.9%	427	411	428	414	383	363	372	338	362	336	349	368	469	370	347	394	481	413	431	449	443
Operating Expenses	26.9%	443	349	371	365	352	330	379	316	316	-101	475	317	347	291	285	307	178	358	376	347	336
S&GA Expenses	1.6%	153	150	171	168	154	145	151	136	131	130	140	136	157	130	119	140	116	134	140	149	145
R&D Expenses	0%	30.00	30.00	32.00	31.00	33.00	30.00	32.00	29.00	30.00	28.00	33.00	31.00	33.00	30.00	30.00	28.00	-8.85	44.00	44.00	40.00	45.00
EBITDA Margin	-	0.04*	-	0.11*	0.11*	0.11*	0.10*	0.10*	0.11*	0.12*	0.12*	0.12*	0.13*	0.13*	-	-	-	-	-	-	-	-
Interest Expenses	2.0%	-42.65	-43.50	-44.00	-43.70	-40.90	-41.00	-38.30	-35.80	-30.50	-30.90	-31.60	-32.00	-33.35	-33.30	-32.20	-28.90	-27.15	-30.50	-31.20	-28.60	-32.80
Income Taxes	-801.3%	-26.65	4.00	14.00	5.00	-1.65	49.00	-43.40	-11.70	-22.20	443	-45.20	14.00	-63.20	22.00	3.00	-0.20	-50.80	5.00	18.00	17.00	122
EBT Margin	-Infinity%	0.00*	-	0.06*	0.06*	0.07*	0.07*	0.07*	0.07*	0.07*	0.07*	0.07*	0.07*	0.07*	-	-	-	-	-	-	-	-
Net Income	-327.5%	-32.30	14.00	8.00	-3.00	-23.70	-49.40	-65.10	-2.40	10.00	-58.90	-57.70	38.00	-175	-154	61.00	106	-19.00	92.00	9.00	64.00	82.00
Net Income Margin	-209.6%	0.00*	0.00*	-0.01*	-0.03*	-0.03*	-0.02*	-0.03*	-0.03*	-0.02*	-0.06*	-0.08*	-0.05*	-	-	-	-	-	-	-	-	-
Free Cashflow	96.3%	182	93.00	33.00	-3.80	160	38.00	-45.30	59.00	-147	302	-105	-45.20	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	0.5%	10,809	10,758	10,965	10,955	11,017	10,678	10,920	10,390	10,426	10,916	11,230	11,325	11,488	11,576	12,128	11,401	11,301	11,311	11,429	11,120	10,983
Current Assets	2.4%	2,833	2,765	2,773	2,741	2,720	2,583	2,652	3,936	3,860	4,226	4,420	4,489	3,134	3,398	3,804	3,046	2,731	2,740	3,435	3,009	2,902
Cash Equivalents	25.6%	751	598	555	553	601	469	485	1,966	1,865	2,078	318	471	632	840	1,438	492	345	399	1,056	838	542
Inventory	-0.7%	1,141	1,150	1,168	1,183	1,150	1,085	1,080	1,022	1,020	1,093	1,116	1,136	1,059	1,101	1,035	931	967	991	941	913	878
Net PPE	1.5%	916	903	918	919	926	840	840	846	864	843	834	860	865	919	892	889	774	871	824	821	829
Liabilities	0.3%	6,041	6,020	6,116	6,121	6,175	6,075	6,070	5,285	5,274	5,734	5,719	5,767	5,833	5,756	6,217	5,614	5,497	5,552	5,702	5,419	5,315
Current Liabilities	57.3%	1,586	1,008	1,057	1,087	1,114	1,015	1,015	981	1,588	2,004	1,985	1,447	1,382	1,336	1,860	1,635	1,336	1,325	1,791	1,832	1,537
Long Term Debt	-10.3%	3,633	4,049	4,056	4,063	4,070	4,078	4,086	3,511	2,917	2,921	2,926	3,525	3,528	3,544	3,536	3,183	3,366	3,362	3,084	2,750	3,052
LT Debt, Current	1056.4%	441	38.00	38.00	39.00	36.00	34.00	31.00	5.00	604	629	630	36.00	37.00	17.00	607	288	3.00	3.00	399	468	190
LT Debt, Non Current	-10.3%	3,633	4,049	4,056	4,063	4,070	4,078	4,086	3,511	2,917	2,921	2,926	3,525	3,528	3,544	3,536	3,183	3,366	3,362	3,084	2,750	3,052
Shareholder's Equity	0.6%	4,768	4,738	4,849	4,834	4,842	4,603	4,850	5,105	5,152	5,182	5,511	5,558	5,655	5,820	5,910	5,786	5,804	5,759	5,726	5,701	5,668
Retained Earnings	-1.6%	-2,080	-2,048	-2,062	-2,070	-2,067	-2,043	-1,994	-1,929	-1,927	-1,936	-1,877	-1,820	-1,858	-1,683	-1,528	-1,589	-1,695	-1,676	-1,768	-1,777	-1,838
Shares Outstanding	0%	136	136	135	135	135	135	135	134	134	134	133	133	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Float	-	-	-	4,596	-	-	-	5,521	-	-	-	6,266	-	-	-	7,361	-	-	-	6,477	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	67.6%	209	125	53.00	19.00	186	59.00	-16.90	79.00	-105	344	-82.30	0.00	110	63.00	291	172	90.00	140	64.00	95.00	194
Share Based Compensation	-27.9%	11.00	15.00	19.00	25.00	8.00	9.00	11.00	26.00	10.00	11.00	14.00	25.00	15.00	14.00	14.00	16.00	11.00	13.00	16.00	12.00	11.00
Cashflow From Investing	25.7%	-22.80	-30.70	-4.40	-19.60	-26.00	-20.90	-1,974	63.00	-41.90	1,454	-21.80	-114	-127	-38.60	53.00	-74.80	-106	-651	-68.10	230	-46.10
Cashflow From Financing	-3.0%	-44.60	-43.30	-48.60	-50.70	-42.50	-43.00	559	-51.90	-58.00	-36.30	-41.10	-43.30	-201	-646	602	65.00	-31.50	-144	220	-41.60	-34.30
Dividend Payments	-3.3%	38.00	39.00	37.00	36.00	35.00	37.00	35.00	34.00	32.00	33.00	33.00	33.00	31.00	31.00	31.00	31.00	29.00	29.00	29.00	26.00	26.00
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PRGO Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 4,655.6	$ 4,451.6	$ 4,138.7
Cost of sales	2,975.2	2,996.2	2,722.5
Gross profit	1,680.4	1,455.4	1,416.2
Operating expenses
Distribution	110.5	113.0	93.0
Research and development	122.5	123.1	122.0
Selling	641.8	584.8	536.4
Administration	522.3	512.3	482.0
Impairment charges	90.0	0.0	173.1
Restructuring	42.2	42.5	16.9
Other operating (income) expense, net	(0.8)	0.8	(417.6)
Total operating expenses	1,528.5	1,376.5	1,005.8
Operating income	151.9	78.9	410.4
Interest Expense, net	173.8	156.0	125.0
Other (income) expense, net	(10.4)	53.1	26.7
(Gain) loss on extinguishment of debt	(3.2)	8.9	0.0
Income (loss) from continuing operations before income taxes	(8.3)	(139.1)	258.7
Income tax (benefit) expense	(3.9)	(8.2)	389.6
Income (loss) from continuing operations	(4.4)	(130.9)	(130.9)
Income (loss) from discontinued operations, net of tax	(8.3)	(9.7)	62.0
Net income (loss)	$ (12.7)	$ (140.6)	$ (68.9)
Basic
Continuing operations (in dollars per share)	$ (0.03)	$ (0.97)	$ (0.98)
Discontinued operations (in dollars per share)	(0.06)	(0.07)	0.46
Basic (in dollars per share)	(0.09)	(1.04)	(0.52)
Diluted
Continuing operations (in dollars per share)	(0.03)	(0.97)	(0.98)
Discontinued operations (in dollars per share)	(0.06)	(0.07)	0.46
Diluted (in dollars per share)	$ (0.09)	$ (1.04)	$ (0.52)
Weighted-average shares outstanding
Basic (in shares)	135.3	134.5	133.6
Diluted (in shares)	135.3	134.5	133.6

PRGO Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Assets
Cash, cash equivalents and restricted cash	$ 751.3	$ 600.7
Accounts receivable, net of allowance for credit losses of $7.8 and $6.8, respectively	739.6	697.1
Inventories	1,140.9	1,150.3
Prepaid expenses and other current assets	201.1	271.8
Total current assets	2,832.9	2,719.9
Property, plant and equipment, net	916.4	926.3
Operating lease assets	183.6	217.1
Goodwill and indefinite-lived intangible assets	3,534.4	3,549.0
Definite-lived intangible assets, net	2,980.8	3,230.2
Deferred income taxes	25.8	7.1
Other non-current assets	335.2	367.7
Total non-current assets	7,976.2	8,297.4
Total assets	10,809.1	11,017.3
Liabilities and Shareholders’ Equity
Accounts payable	477.7	537.3
Payroll and related taxes	127.0	136.4
Accrued customer programs	163.5	139.1
Other accrued liabilities	335.4	250.2
Accrued income taxes	42.1	14.4
Current indebtedness	440.6	36.2
Total current liabilities	1,586.3	1,113.6
Long-term debt, less current portion	3,632.8	4,070.4
Deferred income taxes	262.3	368.2
Other non-current liabilities	559.8	623.0
Total non-current liabilities	4,454.9	5,061.6
Total liabilities	6,041.2	6,175.2
Contingencies - Refer to Note 19
Controlling interests:
Preferred shares, $0.0001 par value per share, 10 shares authorized	0.0	0.0
Ordinary shares, €0.001 par value per share, 10,000 shares authorized	6,837.5	6,936.7
Accumulated other comprehensive income	10.7	(27.0)
Retained earnings (accumulated deficit)	(2,080.3)	(2,067.6)
Total shareholders’ equity	4,767.9	4,842.1
Total liabilities and shareholders' equity	$ 10,809.1	$ 11,017.3
Supplemental Disclosures of Balance Sheet Information
Preferred shares, issued (in shares)	0.0	0.0
Preferred shares, outstanding (in shares)	0.0	0.0
Ordinary shares, issued (in shares)	135.5	134.7
Ordinary shares, outstanding (in shares)	135.5	134.7

About Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women's health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada. This segment offers its products under Burt's Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands. Consumer Self-Care International segment comprises consumer self-care product categories outside the U.S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe. In addition, the company offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

CEO	Mr. Patrick Lockwood-Taylor
WEBSITE	perrigo.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	8900

Perrigo Co PLC Frequently Asked Questions

What is the ticker symbol for Perrigo Co PLC? What does PRGO stand for in stocks?

PRGO is the stock ticker symbol of Perrigo Co PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Perrigo Co PLC (PRGO)?

As of Thu May 02 2024, market cap of Perrigo Co PLC is 4.48 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRGO stock?

You can check PRGO's fair value in chart for subscribers.

What is the fair value of PRGO stock?

You can check PRGO's fair value in chart for subscribers. The fair value of Perrigo Co PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Perrigo Co PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PRGO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Perrigo Co PLC a good stock to buy?

The fair value guage provides a quick view whether PRGO is over valued or under valued. Whether Perrigo Co PLC is cheap or expensive depends on the assumptions which impact Perrigo Co PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRGO.

What is Perrigo Co PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 02 2024, PRGO's PE ratio (Price to Earnings) is -352.87 and Price to Sales (PS) ratio is 0.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRGO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Perrigo Co PLC's stock?

In the past 10 years, Perrigo Co PLC has provided -0.129 (multiply by 100 for percentage) rate of return.